This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Quinkler, M. Articles by Diederich, S. Search for Related Content PubMed PubMed Citation Articles by Quinkler, M. Articles by Diederich, S.

The Human Kidney Is a Progesterone-Metabolizing and Androgen-Producing Organ

Department of Endocrinology, Klinikum Benjamin Franklin, Free University, 12200 Berlin, Germany

Address all correspondence and requests for reprints to: Dr. Marcus Quinkler, Division of Medical Sciences, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom B15 2TH. E-mail: m.o.quinkler{at}bham.ac.uk.

Progesterone (P) is a potent antagonist of the human mineralocorticoid receptor (MR) in vitro. We have previously demonstrated effective downstream metabolism of P in the kidney. This mechanism potentially protects the MR from P action. Here, we have investigated the expression and functional activity of steroidogenic enzymes in human kidney. RT-PCR analysis demonstrated the expression of 5-reductase type 1, 5ß-reductase, aldo-keto-reductase (AKR) 1C1, AKR1C2, AKR1C3, 3ß-hydroxysteroid dehydrogenase (3ß-HSD) type 2, and 17-hydroxylase/17,20-lyase (P450c17). The presence of 3ß-HSD type 2 and P450c17 indicated that conversion of pregnenolone to dehydroepiandrosterone (DHEA) and to androstenedione may take place effectively in kidney. To investigate this further, we incubated kidney subcellular fractions with radiolabeled pregnenolone. This resulted in efficient formation of DHEA from pregnenolone, indicating both 17-hydroxylase and 17,20-lyase activities exerted by P450c17. Radiolabeled DHEA was converted via androstenedione, androstenediol, and testosterone, indicating both 3ß-HSD type 2 activity and 17ß-HSD activity. In addition, the conversion of testosterone to 5-dihydrotestosterone was detectable, indicating 5-reductase activity. In conclusion, we verified the expression and functional activity of several enzymes involved in downstream metabolism of P and androgen synthesis in human kidney. These findings may be critical to the understanding of water balance during the menstrual cycle and pregnancy and of sex differences in hypertension.

This work was supported by Research Grant DI 741/1-3 from the Deutsche Forschungsgemeinschaft (to S.D.) and Deutsche Forschungsgemeinschaft Postdoctoral Research Fellowship Grant QU142/1-1 (to M.Q.).

Abbreviations: AKR, Aldo-keto-reductase; 20-DH-P, 20-dihydroprogesterone; DHEA, dehydroepiandrosterone; DH-T, dihydrotestosterone; 3-diol, 3-androstanediol; 4-dione, androstenedione; 3ß-HSD, 3ß-hydroxysteroid dehydrogenase; MR, mineralocorticoid receptor; 17-OH-P, 17-hydroxyprogesterone; 17-OH-Preg, 17-hydroxypregnenolone; P, progesterone; P450c17, 17-hydroxylase/17,20-lyase; Preg, pregnenolone; T, testosterone; 3ß,5-TH-P, 5-pregnan-3ß-ol-20-one; TLC, thin layer chromatography; V_max, maximal reaction velocity.

This article has been cited by other articles:

				J. Sun, K. Devish, W. J. Langer, P. K. Carmines, and P. H. Lane Testosterone treatment promotes tubular damage in experimental diabetes in prepubertal rats Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1681 - F1690. [Abstract] [Full Text] [PDF]

				J. F. Reckelhoff, L. L. Yanes, R. Iliescu, L. A. Fortepiani, and J. P. Granger Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease Am J Physiol Renal Physiol, November 1, 2005; 289(5): F941 - F948. [Abstract] [Full Text] [PDF]

				M. Quinkler, I. J. Bujalska, K. Kaur, C. U. Onyimba, S. Buhner, B. Allolio, S. V. Hughes, M. Hewison, and P. M. Stewart Androgen Receptor-Mediated Regulation of the {alpha}-Subunit of the Epithelial Sodium Channel in Human Kidney Hypertension, October 1, 2005; 46(4): 787 - 798. [Abstract] [Full Text] [PDF]

				R. K. Bledsoe, K. P. Madauss, J. A. Holt, C. J. Apolito, M. H. Lambert, K. H. Pearce, T. B. Stanley, E. L. Stewart, R. P. Trump, T. M. Willson, et al. A Ligand-mediated Hydrogen Bond Network Required for the Activation of the Mineralocorticoid Receptor J. Biol. Chem., September 2, 2005; 280(35): 31283 - 31293. [Abstract] [Full Text] [PDF]

				S. Liu, H. Ishikawa, F.-J. Li, Z. Ma, K.-i. Otsuyama, H. Asaoku, S. Abroun, X. Zheng, N. Tsuyama, M. Obata, et al. Dehydroepiandrosterone Can Inhibit the Proliferation of Myeloma Cells and the Interleukin-6 Production of Bone Marrow Mononuclear Cells from Patients with Myeloma Cancer Res., March 15, 2005; 65(6): 2269 - 2276. [Abstract] [Full Text] [PDF]